CONCORD, Calif.--(BUSINESS WIRE)--July 17, 2008--Cerus Corporation (NASDAQ: CERS) announced today that its second quarter financial results will be released on Thursday, July 31, 2008 and that it will host a conference call and live webcast at 4:30 p.m. EDT that afternoon. Management will discuss the company's second quarter results and provide an overview of the company.

To access the webcast, log on to the Investor Relations page of the Cerus Web site at www.cerus.com. Alternatively, you may access the live conference call by dialing 877-407-0782 (U.S.) or 201-689-8567 (International). A telephone and webcast replay will be available approximately two hours after the call through August 6, 2008. The replay can be accessed by dialing 877-660-6853 (U.S.) or 201-612-7415 (International), and entering account number 286 and conference ID number 285639. The webcast will be archived on www.cerus.com.

ABOUT CERUS

Cerus Corporation is a biomedical products company focused on commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System is designed to inactivate blood-borne pathogens in donated blood components intended for transfusion. Cerus currently markets the INTERCEPT Blood System for both platelets and plasma in Europe and the Middle East. The Company is also pursuing regulatory approvals in the United States and other countries. The INTERCEPT red blood cell system is currently in clinical development.

INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.

CONTACT: Cerus Corporation
William J. Dawson, Vice President, Finance & CFO
925-288-6053
bdawson@cerus.com
or
Porter Novelli Life Sciences
Jason I. Spark, 619-849-6005
jspark@pnlifesciences.com

SOURCE: Cerus Corporation